Principal and Director, Business Development @ (October 2016 - March 2025)
Board Director, Microbion @ (August 2020 - February 2025)
Board Director, IOME @ (November 2021 - July 2024)
Board Director, ARTMS @ (July 2023 - March 2024)
Member, Research Management Committee @ https://www.nanomedicines.ca/ (May 2019 - March 2024)
Board Director, Canary Medical @ (June 2020 - March 2023)
Interim CEO, Sitka Biopharma @ (March 2020 - June 2022)
Interim CEO @ (January 2018 - September 2019)
Associate Director, Partnerships @ The Centre for Drug Research and Development (April 2014 - October 2016)
Manager, Business Development @ The Centre for Drug Research and Development (November 2010 - April 2014)
Scientist, Project Evaluation @ The Centre for Drug Research and Development (March 2008 - November 2010)
Student, PhD @ (January 2002 - January 2007)
Student, PhD @
Kaley Wilson Education
The University of British Columbia
PhD (Immunology; Biochemistry; Cancer)
2002-2007
Kaley Wilson Skills
Lifesciences
Biochemistry
Biotechnology
Drug Discovery
Molecular Biology
Cell
Technology Transfer
Cell Biology
Drug Development
Protein Purification
Protein Chemistry
Cell Culture
Immunology
Proteomics
PCR
Life Sciences
Science
Public Speaking
Marketing
Management
Social Media
Microsoft Excel
Customer Service
Sales
Kaley Wilson Summary
Kaley Wilson, based in Vancouver, BC, CA, is currently a Vice President, Business Development at NanoVation Therapeutics™. Kaley Wilson brings experience from previous roles at SeraGene Therapeutics, NZ Technologies, Crohn's and Colitis Canada and GlycoNet. Kaley Wilson holds a 2002 - 2007 PhD in Immunology; Biochemistry; Cancer @ The University of British Columbia. With a robust skill set that includes Lifesciences, Biochemistry, Biotechnology, Drug Discovery, Molecular Biology and more. Kaley Wilson has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kaley Wilson?
Find contact details for 700 million professionals.